Stock Price Targets and Analyst Ratings

Stay on top of the latest U.S. and international stock analyst recommendations with our up-to-date list of stock price targets and analyst ratings. This page tracks newly issued analyst ratings, price targets, upgrades, downgrades, and other broker actions to help you see how Wall Street analysts view the companies you follow. Use these ratings to compare sentiment, spot shifts in outlook, and make more informed investment decisions.

Company	Action	Brokerage	Analyst	Current Price	Price Target	Rating
A Agilent Technologies	Target Raised by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Luke Sergott Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$139.08 +20.1%	$140.00 ➝ $145.00	Overweight
A Agilent Technologies	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brandon Couillard Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$139.08 +20.1%	$165.00 ➝ $160.00	Overweight
A Agilent Technologies	Target Raised by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Dan Brennan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$139.08 +20.1%	$147.00 ➝ $155.00	Buy
A Agilent Technologies	Upgraded by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Derik De Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$139.08 +20.1%	$150.00 ➝ $145.00	Neutral ➝ Buy
ABEO Abeona Therapeutics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Raghuram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$5.78 +1.7%	$20.00	Buy
ABSI Absci	Initiated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kambiz Yazdi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$6.09 +17.9%	$9.00	Buy
ACA Arcosa	Initiated by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brent Thielman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$126.97 +0.2%	$150.00	Outperform
AFRM Affirm	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew Coad Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$72.95 +3.6%	$75.00 ➝ $80.00	Buy
AHR American Healthcare REIT	Target Raised by	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Austin Wurschmidt Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$49.84 -1.2%	$55.00 ➝ $58.00	Overweight
ALGS Aligos Therapeutics	Initiated by	Lake Street Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Daniel Brims Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$5.84 +4.3%	$45.00	Buy
How to claim a stake in SpaceX before the June 12 IPO (Ad) SpaceX is expected to go public on June 12 - and for the first time, everyday investors may have a way in before the IPO. Jeff Brown, who identified Bitcoin, Tesla, and Nvidia before gains as high as 52,400%, 2,150%, and 32,000% respectively, is sharing the details on how to claim a stake in Elon Musk's company before it hits public markets. See exactly how to position yourself in SpaceX before June 12
ALL Allstate	Reiterated by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Paul Newsome Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$208.34 -0.2%		Overweight
AMAT Applied Materials	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	C.J. Muse Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$447.03 -0.3%	$575.00	Overweight
AMAT Applied Materials	Target Set by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$447.03 -0.3%	$575.00
ANF Abercrombie & Fitch	Target Set by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$81.72 +0.4%	$136.00
ANF Abercrombie & Fitch	Target Lowered by	Telsey Advisory Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$81.72 +0.4%	$125.00 ➝ $115.00	Outperform
ANL Adlai Nortye	Initiated by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jay Olson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$11.35 +3.2%	$32.00	Outperform
APGE Apogee Therapeutics	Target Set by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$78.07 +0.4%	$89.00
APH Amphenol	Target Raised by	BNP Paribas Exane Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$147.24 +5.0%	$195.00 ➝ $200.00	Outperform
APP AppLovin	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bernie McTernan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$601.77 +6.0%	$700.00	Buy
ASMB Assembly Biosciences	Reiterated by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Vamil Divan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$27.49 +0.3%	$43.00	Buy
ATD Alimentation Couche-Tard	Target Raised by	National Bank Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$77.32 -1.3%	C$89.00 ➝ C$91.00	Outperform
ATRO Astronics	Target Raised by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gautam Khanna Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$87.95 +3.5%	$85.00 ➝ $100.00	Buy
AV Aviva	Reiterated by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 627.20 -0.2%	GBX 800 ➝ GBX 800	Buy
AVGO Broadcom	Reiterated by	Susquehanna Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Christopher Rolland Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$427.58 +1.4%	$450.00 ➝ $490.00	Positive
BAX Baxter International	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joanne Wuensch Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$19.16 -0.9%	$19.00 ➝ $17.00	Neutral ➝ Sell
BBD.A Bombardier	Target Raised by	Scotia Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$300.76 +3.6%	C$305.00 ➝ C$330.00	Sector Outperform
BBIO BridgeBio Pharma	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sean Laaman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$67.42 +1.5%	$94.00 ➝ $98.00	Overweight
BBIO BridgeBio Pharma	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Raghuram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$67.42 +1.5%	$110.00	Buy
BBWI Bath & Body Works	Target Lowered by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kate McShane Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$20.34 +4.6%	$26.00 ➝ $23.00	Neutral
BBWI Bath & Body Works	Target Lowered by	Telsey Advisory Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$20.34 +4.6%	$25.00 ➝ $22.00	Market Perform
BBWI Bath & Body Works	Target Raised by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jonna Kim Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$20.34 +4.6%	$20.00 ➝ $25.00	Buy
BBWI Bath & Body Works	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ike Boruchow Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$20.34 +4.6%	$29.00 ➝ $25.00	Overweight
BBWI Bath & Body Works	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Adrienne Yih Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$20.34 +4.6%	$25.00 ➝ $23.00	Equal Weight
BDRBF Bombardier	Reiterated by	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$216.69 +2.9%		Outperform
BE Bloom Energy	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Vikram Bagri Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$301.69 +2.7%		Neutral
BMO Bank Of Montreal	Reiterated by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$162.44 -0.4%		Underweight
BMO Bank Of Montreal	Reiterated by	Desjardins Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$162.44 -0.4%		Hold
BMO Bank Of Montreal	Reiterated by	TD Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$162.44 -0.4%		Buy
BMO Bank Of Montreal	Reiterated by	Canadian Imperial Bank of Commerce Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$162.44 -0.4%		Outperform
BMO Bank of Montreal	Target Raised by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$224.38 -0.5%	C$199.00 ➝ C$203.00	Underweight
A letter from Shannon Stansberry (Ad) Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down year in nearly two decades and total gains of almost 2,000% - his immediate reaction was disbelief. It took a trusted friend's personal vouching for Emmet Savage and a face-to-face trip to Ireland to change his mind. The full documentary, Investigating Project Prophet, is now live. Watch the full story and see the verified track record for yourself
BMO Bank of Montreal	Target Raised by	Desjardins Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$224.38 -0.5%	C$212.00 ➝ C$230.00	Hold
BMO Bank of Montreal	Target Raised by	National Bank Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$224.38 -0.5%	C$223.00 ➝ C$236.00	Sector Perform
BMO Bank of Montreal	Target Raised by	TD Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$224.38 -0.5%	C$234.00 ➝ C$239.00	Buy
BMO Bank of Montreal	Target Raised by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$224.38 -0.5%	C$205.00 ➝ C$230.00	Sector Perform
BMO Bank of Montreal	Target Raised by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$224.38 -0.5%	C$227.00 ➝ C$233.50	Outperform
BMO Bank of Montreal	Target Raised by	Canadian Imperial Bank of Commerce Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$224.38 -0.5%	C$226.00 ➝ C$244.00	Outperformer
BMY Bristol Myers Squibb	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$56.85 -1.2%		Buy
BNS Bank of Nova Scotia	Target Raised by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Darko Mihelic Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$79.78 -1.1%	$98.00 ➝ $117.00	Sector Perform
BNS Bank of Nova Scotia	Target Raised by	Canadian Imperial Bank of Commerce Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$110.16 -1.3%	C$116.00 ➝ C$122.00	Neutral
BNS Bank of Nova Scotia	Target Raised by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$110.16 -1.3%	C$108.00 ➝ C$110.00	Equal Weight
BNS Bank of Nova Scotia	Target Raised by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$110.16 -1.3%	C$120.00 ➝ C$121.00	Outperform
BNS Bank of Nova Scotia	Target Raised by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$110.16 -1.3%	C$98.00 ➝ C$117.00	Sector Perform
BNS Bank of Nova Scotia	Target Raised by	TD Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$110.16 -1.3%	C$112.00 ➝ C$113.00	Hold
BNS Bank of Nova Scotia	Target Raised by	Desjardins Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$110.16 -1.3%	C$108.00 ➝ C$115.00	Hold
BOLT Bolt Biotherapeutics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Robert Burns Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$5.28 0.0%	$7.00	Buy
BOWL Hollywood Bowl Group	Reiterated by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 306 +2.0%	GBX 376 ➝ GBX 376	Buy
BOY Bodycote	Upgraded by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 817 -1.6%	GBX 835 ➝ GBX 960	Buy
BRZE Braze	Reiterated by	Citizens Jmp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick Walravens Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$22.81 -7.2%	$35.00	Market Outperform
BRZE Braze	Reiterated by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Clark Wright Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$22.81 -7.2%	$33.00	Buy
BRZE Braze	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew VanVliet Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$22.81 -7.2%	$38.00	Overweight
BRZE Braze	Reiterated by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Billy Fitzsimmons Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$22.81 -7.2%	$27.00	Overweight
BRZE Braze	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Taylor McGinnis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$22.81 -7.2%		Outperform
BRZE Braze	Target Lowered by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Siti Panigrahi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$22.81 -7.2%	$40.00 ➝ $32.00	Outperform
BRZE Braze	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tyler Radke Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$22.81 -7.2%		Market Outperform
BRZE Braze	Target Lowered by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Hynes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$22.81 -7.2%	$40.00 ➝ $35.00	Buy
BRZE Braze	Target Set by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Parker Lane Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$22.81 -7.2%	$30.00
BSX Boston Scientific	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matt Miksic Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$49.39 -2.1%	$96.00 ➝ $89.00	Overweight
BSX Boston Scientific	Target Lowered by	Leerink Partners Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mike Kratky Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$49.39 -2.1%	$87.00 ➝ $74.00	Outperform
BSX Boston Scientific	Target Set by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Roman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$49.39 -2.1%	$71.00
BSX Boston Scientific	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joanne Wuensch Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$49.39 -2.1%		Buy
BSX Boston Scientific	Target Set by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Rescott Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$49.39 -2.1%	$70.00
BSX Boston Scientific	Reiterated by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Larry Biegelsen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$49.39 -2.1%	$75.00 ➝ $55.00	Overweight ➝ Equal Weight
BSX Boston Scientific	Reiterated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Shagun Singh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$49.39 -2.1%		Outperform
BYPLF Bodycote	Reiterated by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$9.55		Buy
CARG CarGurus	Initiated by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Babcock Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$30.11 +4.2%	$35.00	Overweight
CARG CarGurus	Target Set by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kunal Madhukar Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$30.11 +4.2%	$35.00
CARR Carrier Global	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Chris Snyder Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$63.91 -0.9%	$55.00 ➝ $60.00	Equal Weight
CCC Computacenter	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 4,250 +0.8%	GBX 4,400 ➝ GBX 4,400	Buy
CDNL Cardinal Infrastructure Group	Initiated by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brent Thielman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$52.33 +5.4%	$60.00	Outperform
CELC Celcuity	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$131.08 -2.2%		Market Outperform
CF CF Industries	Target Raised by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$116.86 +0.4%	$86.00 ➝ $106.00	Hold
CHRT Cohort	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 1,474 +8.4%	GBX 1,290 ➝ GBX 1,290	Hold
CHRT Cohort	Reiterated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 1,474 +8.4%	GBX 1,740 ➝ GBX 1,740	Outperform
CIZN Citizens	Initiated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$9.40		Market Outperform
CIZN Citizens	Target Set by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$9.40	$18.00
CLLS Cellectis	Initiated by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lukas Shumway Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$3.60 -0.8%	$9.00	Overweight
CM Canadian Imperial Bank of Commerce	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$109.27 -5.3%		Hold
COIN Coinbase Global	Target Raised by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Yaro Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$181.52 +4.5%	$226.00 ➝ $228.00	Buy
COO Cooper Companies	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$61.22 +0.7%		Neutral
CORT Corcept Therapeutics	Target Set by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ashwani Verma Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$69.40 +4.1%	$135.00
Elon’s big June 30 announcement (Ad) Most investors are focused on the historic $1.75 trillion SpaceX IPO expected around June 30. But there's a lesser-known angle that could matter more to your portfolio. One under-the-radar tech firm has already shipped 5 billion critical components to SpaceX - making it a linchpin of the operation. Because SpaceX has been private, this partnership has gone almost entirely unnoticed by Wall Street. Get the name of this overlooked SpaceX supplier before the June 30 deadline
CORT Corcept Therapeutics	Target Raised by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Swayampakula Ramakanth Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$69.40 +4.1%	$75.00 ➝ $95.00	Buy
CORT Corcept Therapeutics	Target Raised by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Edward Nash Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$69.40 +4.1%	$110.00 ➝ $135.00	Buy
CPRI Capri	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$19.83 +8.5%	$20.00	Neutral
CPRI Capri	Reiterated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Robert Drbul Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$19.83 +8.5%	$30.00	Buy
CPRI Capri	Target Lowered by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lorraine Hutchinson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$19.83 +8.5%	$23.00 ➝ $20.00	Neutral
CPRI Capri	Target Lowered by	Telsey Advisory Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$19.83 +8.5%	$23.00 ➝ $21.00	Market Perform
CPRI Capri	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ike Boruchow Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$19.83 +8.5%	$21.00 ➝ $20.00	Equal Weight
CPRI Capri	Reiterated by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$19.83 +8.5%	$22.00	Outperform
CPRX Catalyst Pharmaceuticals	Downgraded by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew S. Fein Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$31.31 0.0%	$35.00 ➝ $31.50	Buy ➝ Neutral
CRM Salesforce	Target Lowered by	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jackson Ader Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$176.55 -0.5%	$300.00 ➝ $290.00	Overweight
CRM Salesforce	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tyler Radke Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$176.55 -0.5%		Market Outperform
CRM Salesforce	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Karl Keirstead Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$176.55 -0.5%		Market Outperform
CRM Salesforce	Target Lowered by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Hynes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$176.55 -0.5%	$250.00 ➝ $225.00	Buy
CRM Salesforce	Target Lowered by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Keith Bachman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$176.55 -0.5%	$225.00 ➝ $215.00	Outperform
CRM Salesforce	Reiterated by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Billy Fitzsimmons Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$176.55 -0.5%	$215.00	Overweight
CRM Salesforce	Reiterated by	Wedbush Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Dan Ives Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$176.55 -0.5%	$325.00	Outperform
CRM Salesforce	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Raimo Lenschow Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$176.55 -0.5%	$252.00 ➝ $236.00	Overweight
CRM Salesforce	Target Lowered by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mark Moerdler Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$176.55 -0.5%	$194.00 ➝ $173.00	Underperform
CRM Salesforce	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Turrin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$176.55 -0.5%	$210.00 ➝ $200.00	Equal Weight
CRM Salesforce	Reiterated by	Citizens Jmp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick Walravens Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$176.55 -0.5%	$315.00	Market Outperform
CRM Salesforce	Target Lowered by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gil Luria Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$176.55 -0.5%	$200.00 ➝ $175.00	Neutral
CRM Salesforce	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew VanVliet Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$176.55 -0.5%	$250.00	Overweight
CRM Salesforce	Target Raised by	B. Riley Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Craig Ellis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$176.55 -0.5%	$205.00 ➝ $240.00	Buy
CRM Salesforce	Target Lowered by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Derrick Wood Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$176.55 -0.5%	$250.00 ➝ $240.00	Buy
CRM Salesforce	Reiterated by	Roth Mkm Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$176.55 -0.5%	$325.00	Buy
CTRN Citi Trends	Reiterated by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Baker Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$51.23 +9.9%	$68.00	Buy
CTVA Corteva	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Vincent Andrews Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$80.48 +0.7%	$84.00 ➝ $95.00	Overweight
CVO Coveo Solutions	Target Lowered by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$3.74 -19.7%	C$10.00 ➝ C$6.00	Outperform
CVO Coveo Solutions	Target Lowered by	TD Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$3.74 -19.7%	C$9.50 ➝ C$6.50	Buy
D Dominion Energy	Upgraded by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Paul Zimbardo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$67.74 +0.8%	$65.00 ➝ $76.00	Hold ➝ Buy
DDOG Datadog	Target Raised by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$228.36 +3.0%	$225.00 ➝ $260.00
DELL Dell Technologies	Target Set by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Vijay Rakesh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$321.58 +5.3%	$350.00
DKS DICK'S Sporting Goods	Reiterated by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ike Boruchow Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$228.61 +4.3%		Positive
DKS DICK'S Sporting Goods	Target Set by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$228.61 +4.3%	$264.00
DKS DICK'S Sporting Goods	Target Raised by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Adrienne Yih Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$228.61 +4.3%	$264.00 ➝ $280.00	Overweight
DKS DICK'S Sporting Goods	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Simeon Gutman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$228.61 +4.3%	$250.00 ➝ $270.00	Overweight
DKS DICK'S Sporting Goods	Reiterated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Robert Drbul Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$228.61 +4.3%	$300.00	Buy
DKS DICK'S Sporting Goods	Upgraded by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Christopher Horvers Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$228.61 +4.3%	$240.00 ➝ $270.00	Neutral ➝ Overweight
DKS DICK'S Sporting Goods	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ike Boruchow Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$228.61 +4.3%	$200.00 ➝ $220.00	Equal Weight
DKS DICK'S Sporting Goods	Reiterated by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Baker Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$228.61 +4.3%	$260.00	Buy
DLTR Dollar Tree	Target Set by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Lasser Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$111.65 +16.5%	$124.00
DMRA Damora Therapeutics, Inc. Common Stock	Initiated by	Wedbush Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Nierengarten Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$24.79 -1.7%	$35.00	Outperform
DRTS Alpha Tau Medical	Initiated by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lukas Shumway Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$10.22 -0.7%	$15.00	Overweight
DXCM DexCom	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joanne Wuensch Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$72.70 +3.5%		Buy
DY Dycom Industries	Target Raised by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joseph Osha Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$542.34 +2.5%	$575.00 ➝ $620.00	Buy
DY Dycom Industries	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Eric Luebchow Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$542.34 +2.5%	$500.00 ➝ $650.00	Overweight
DY Dycom Industries	Target Raised by	B. Riley Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Liam Burke Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$542.34 +2.5%	$485.00 ➝ $625.00	Buy
EA Electronic Arts	Reiterated by	Argus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joseph Bonner Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$201.05 +0.2%		Buy ➝ Hold
EADSY Airbus	Reiterated by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$51.73 +2.7%		Overweight
ECG Everus Construction Group	Initiated by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ian Zaffino Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$150.94 -0.4%	$185.00	Outperform
Hidden on Tesla's filing: A $12 billion "super startup" (Ad) Tesla's most recent SEC filing contains a single line showing $12 billion in revenue from a new venture Elon Musk has been quietly building inside the company — one that has nothing to do with cars, robots, space, or AI. Blackstone calls the underlying opportunity a $23 trillion market. On July 22, Elon is expected to go public with it. Former hedge fund manager Adam O'Dell says he already knows what's coming — and is sharing the name and ticker of one of his top picks to play it, free. Watch Adam O'Dell's full briefing and claim your free ticker now
EFXT Enerflex	Target Raised by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$25.28 -0.2%	$45.00 ➝ $46.00	Outperform
EFXT Enerflex	Target Raised by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Keith Mackey Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$25.28 -0.2%	$31.00 ➝ $32.00	Outperform
EHC Encompass Health	Initiated by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ryan Langston Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$104.96 +0.6%	$125.00	Buy
ELTX Elicio Therapeutics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Robert Burns Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$10.49 -2.6%	$17.00	Buy
EME EMCOR Group	Target Set by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brent Thielman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$850.71 -0.5%	$1,100.00
EME EMCOR Group	Initiated by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brent Thielman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$850.71 -0.5%	$1,100.00	Outperform
EQ Equillium	Upgraded by	Leerink Partners Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Thomas Smith Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$2.94 +11.7%	$1.00 ➝ $6.00	Market Perform ➝ Outperform
EQ Equillium	Reiterated by	Roth Mkm Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Adam Walsh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$2.94 +11.7%	$12.00	Buy
EQ Equillium	Target Set by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Alex Thompson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$2.94 +11.7%	$5.00
EQ Equillium	Reiterated by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Martin Auster Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$2.94 +11.7%	$7.00	Strong-Buy
EQB EQB	Target Lowered by	TD Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$118.81 +4.1%	C$132.00 ➝ C$123.00	Buy
ETOR eToro Group	Target Raised by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Yaro Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$39.70 +2.8%	$39.00 ➝ $43.00	Neutral
ETSY Etsy	Target Raised by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Curtis Nagle Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$66.61 +4.4%	$72.00 ➝ $75.00	Neutral
FAN Volution Group	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 608 -1.0%	GBX 840 ➝ GBX 840	Buy
FIS Fidelity National Information Services	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew Coad Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$42.05 +0.1%	$50.00 ➝ $45.00	Hold
FIX Comfort Systems USA	Initiated by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brent Thielman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1,840.80 -1.4%	$2,200.00	Outperform
FLOC Flowco	Initiated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Scott Gruber Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$24.18 -5.3%	$31.00	Neutral
GH Guardant Health	Downgraded by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$132.17 +3.7%		Buy
GIS General Mills	Target Lowered by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Peter Galbo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$34.05 +1.2%	$42.00 ➝ $36.00	Neutral
GNC Greencore Group	Reiterated by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 211.31 -3.1%	GBX 325 ➝ GBX 325	Buy
GNC Greencore Group	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 211.31 -3.1%	GBX 185 ➝ GBX 185	Hold
GSK GSK	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 1,918 -1.1%	GBX 2,500 ➝ GBX 2,500	Buy
GVA Granite Construction	Initiated by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brent Thielman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$137.32 +2.0%	$170.00	Outperform
HAE Haemonetics	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$67.97 +1.2%		Neutral
HAFC Hanmi Financial	Reiterated by	Brean Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$29.90 -1.9%	$32.00	Buy ➝ Neutral
HAFC Hanmi Financial	Target Set by	Capital One Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$29.90 -1.9%	$32.00
HAL Halliburton	Target Raised by	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$39.27 -0.8%	$42.00 ➝ $46.00	Outperform
HEI Heico	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$339.00 +9.6%		Buy
HEINY Heineken	Downgraded by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$40.04 -3.0%		Buy ➝ Hold
HICL HICL Infrastructure	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 132.60 -0.3%		Hold
HILS Hill & Smith	Upgraded by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 2,770.52 -0.9%	GBX 2,760 ➝ GBX 3,250	Buy
HMR Heidmar Maritime	Target Set by	Maxim Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tate Sullivan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1.19 -5.2%	$2.25
HOOD Robinhood Markets	Reiterated by	Citizens Jmp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Devin Ryan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$83.54 +9.6%	$155.00	Market Outperform
HOOD Robinhood Markets	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$83.54 +9.6%		Market Outperform
HPP Hudson Pacific Properties	Reiterated by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Alexander Goldfarb Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$12.23 -1.5%	$6.50 ➝ $12.00	Neutral
HPQ HP	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$24.69 -3.1%		Neutral
HPQ HP	Target Raised by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Krish Sankar Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$24.69 -3.1%	$20.00 ➝ $26.00	Hold
HPQ HP	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$24.69 -3.1%		Neutral
HPQ HP	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Erik Woodring Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$24.69 -3.1%	$17.00 ➝ $19.00	Underweight
HPQ HP	Target Raised by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Wamsi Mohan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$24.69 -3.1%	$16.00 ➝ $18.00	Underperform
HPQ HP	Target Raised by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tim Long Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$24.69 -3.1%	$16.00 ➝ $19.00	Underweight
HPQ HP	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Aaron Rakers Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$24.69 -3.1%	$18.00 ➝ $20.00	Underweight
HPS.A Hammond Power Solutions	Target Set by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$333.87 +11.0%	C$430.00	Overweight
HSX Hiscox	Reiterated by	Peel Hunt Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 1,765 -2.2%	GBX 1,960 ➝ GBX 1,960	Add
IART Integra LifeSciences	Upgraded by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joanne Wuensch Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$16.46 +8.3%	$11.00 ➝ $16.00	Sell ➝ Neutral
IBM International Business Machines	Reiterated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew Swanson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$261.33 +2.4%		Outperform
IHP IntegraFin	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 335.50 -3.3%	GBX 360 ➝ GBX 360	Hold
IMB Imperial Brands	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 2,786.22 -0.4%	GBX 3,500 ➝ GBX 3,500	Buy
IMNM Immunome	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Supawat Thongthip Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$22.43 +1.4%	$36.00 ➝ $37.00	Buy
IMNM Immunome	Initiated by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lukas Shumway Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$22.43 +1.4%	$36.00	Overweight
Elon’s big June 30 announcement (Ad) Most investors are focused on the historic $1.75 trillion SpaceX IPO expected around June 30. But there's a lesser-known angle that could matter more to your portfolio. One under-the-radar tech firm has already shipped 5 billion critical components to SpaceX - making it a linchpin of the operation. Because SpaceX has been private, this partnership has gone almost entirely unnoticed by Wall Street. Get the name of this overlooked SpaceX supplier before the June 30 deadline
IREN IREN	Target Raised by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brett Knoblauch Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$64.16 -5.4%	$99.00	Overweight
ITGR Integer	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joanne Wuensch Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$89.90 +1.0%		Neutral
JACK Jack In The Box	Downgraded by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$11.34 -3.8%		Buy ➝ Neutral
KIM Kimco Realty	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Lewis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$24.21 -0.9%	$23.00 ➝ $25.00	Hold
KNF Knife River	Initiated by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brent Thielman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$78.07 -0.3%	$95.00	Outperform
KURA Kura Oncology	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$10.00 -2.4%		Market Outperform
KURA Kura Oncology	Target Set by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$10.00 -2.4%	$24.00
KURA Kura Oncology	Target Set by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$10.00 -2.4%	$24.00
KYCCF Keyence	Upgraded by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$487.06 +2.5%		Buy
LINC Lincoln Educational Services	Target Set by	Northland Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$48.18 +0.2%	$60.00
LRLCY L'Oreal	Upgraded by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$90.25 +0.7%		Hold ➝ Buy
LSPD Lightspeed Commerce	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew Coad Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$9.25 +4.3%	$11.00 ➝ $10.00	Hold
LYB LyondellBasell Industries	Upgraded by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Sison Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$68.21 +0.8%	$80.00 ➝ $98.00	Equal Weight ➝ Overweight
MATD Petro Matad	Reiterated by	Shore Capital Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 1.20 -3.2%		House Stock
MDA MDA Space	Target Raised by	Scotia Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$67.64 +5.5%	C$53.00 ➝ C$70.00	Sector Outperform
MDWD MediWound	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Swayampakula Ramakanth Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$14.53 +1.4%	$36.00	Buy
META Meta Platforms	Reiterated by	Rosenblatt Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Barton Crockett Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$633.55 -0.3%	$1,015.00	Buy
MGNI Magnite	Reiterated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew Swanson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$14.14 +5.9%		Outperform
MLI Mueller Industries	Downgraded by	Northcoast Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$125.75 -7.4%		Buy ➝ Neutral
MLM Martin Marietta Materials	Initiated by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brent Thielman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$571.90 -0.4%		Market Perform
MOD Modine Manufacturing	Target Raised by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Noah Kaye Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$273.86 -2.2%	$271.00 ➝ $325.00	Outperform
MOV Movado Group	Target Raised by	BWS Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Hamed Khorsand Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$35.22 +2.7%	$31.50 ➝ $45.00	Buy
MPLT Maplight Therapeutics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Raghuram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$29.71 +0.5%	$45.00	Buy
MRVL Marvell Technology	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tore Svanberg Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$203.75 +2.5%	$230.00	Buy
MRVL Marvell Technology	Target Raised by	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Cody Acree Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$203.75 +2.5%	$130.00 ➝ $275.00	Buy
MRVL Marvell Technology	Target Raised by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Vivek Arya Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$203.75 +2.5%	$200.00 ➝ $240.00	Buy
MRVL Marvell Technology	Upgraded by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rick Schafer Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$203.75 +2.5%		Outperform ➝ Buy
MRVL Marvell Technology	Target Set by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Schneider Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$203.75 +2.5%	$180.00
MRVL Marvell Technology	Reiterated by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$203.75 +2.5%	$240.00	Buy
MRVL Marvell Technology	Target Set by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Simon Leopold Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$203.75 +2.5%	$235.00
MRVL Marvell Technology	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$203.75 +2.5%	$235.00	Buy
MRVL Marvell Technology	Target Set by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tom O\'Malley Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$203.75 +2.5%	$275.00
MRVL Marvell Technology	Reiterated by	William Blair Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$203.75 +2.5%		Outperform
MRVL Marvell Technology	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Aaron Rakers Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$203.75 +2.5%	$195.00 ➝ $240.00	Overweight
MRVL Marvell Technology	Target Set by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Timothy Arcuri Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$203.75 +2.5%	$230.00
MRVL Marvell Technology	Target Raised by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	N. Quinn Bolton Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$203.75 +2.5%	$118.00 ➝ $270.00	Buy
MRVL Marvell Technology	Target Raised by	Rosenblatt Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kevin Cassidy Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$203.75 +2.5%	$190.00 ➝ $240.00	Buy
MRVL Marvell Technology	Target Set by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joseph Moore Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$203.75 +2.5%	$195.00
MRVL Marvell Technology	Target Raised by	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Vinh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$203.75 +2.5%	$130.00 ➝ $260.00	Overweight
MRVL Marvell Technology	Target Set by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	C.J. Muse Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$203.75 +2.5%	$220.00
MRVL Marvell Technology	Target Raised by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rick Schafer Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$203.75 +2.5%	$200.00 ➝ $250.00	Outperform
MRVL Marvell Technology	Target Raised by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joshua Buchalter Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$203.75 +2.5%	$180.00 ➝ $200.00	Hold
MSGE Madison Square Garden Entertainment	Target Raised by	Susquehanna Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joseph Stauff Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$69.76 -0.3%	$77.00 ➝ $80.00	Positive
MSGS Madison Square Garden	Target Raised by	Susquehanna Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joseph Stauff Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$370.69 +1.2%	$404.00 ➝ $429.00	Positive
MTRO Metro Bank	Upgraded by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 165.60 +5.6%	GBX 170 ➝ GBX 195	Outperform
NA National Bank of Canada	Target Raised by	Desjardins Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$203.69 -0.1%	C$215.00 ➝ C$217.00	Buy
NA National Bank of Canada	Target Lowered by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$203.69 -0.1%	C$206.50 ➝ C$203.00	Market Perform
NA National Bank of Canada	Target Raised by	Canadian Imperial Bank of Commerce Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$203.69 -0.1%	C$209.00 ➝ C$221.00	Neutral
NCNO nCino	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mayank Tandon Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$15.90 +4.7%	$25.00	Buy
NCX NorthIsle Copper and Gold	Target Set by	Ventum Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$2.90 -0.3%	C$5.50	Buy
NTIOF National Bank of Canada	Reiterated by	Canadian Imperial Bank of Commerce Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$147.86 +0.9%		Neutral
NTIOF National Bank of Canada	Reiterated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$147.86 +0.9%		Sector Perform
NTIOF National Bank of Canada	Reiterated by	Desjardins Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$147.86 +0.9%		Buy
NTNX Nutanix	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Meta Marshall Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$49.55 +6.4%	$53.00 ➝ $55.00	Equal Weight
NTNX Nutanix	Target Raised by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mike Cikos Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$49.55 +6.4%	$55.00 ➝ $60.00	Buy
NTNX Nutanix	Target Raised by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tim Long Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$49.55 +6.4%	$47.00 ➝ $53.00	Equal Weight
NTNX Nutanix	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Aaron Rakers Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$49.55 +6.4%	$50.00 ➝ $55.00	Equal Weight
NTNX Nutanix	Reiterated by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$49.55 +6.4%		Buy
NTNX Nutanix	Target Raised by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Wamsi Mohan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$49.55 +6.4%	$60.00 ➝ $65.00	Buy
NTNX Nutanix	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$49.55 +6.4%	$62.00	Buy
NTNX Nutanix	Target Set by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$49.55 +6.4%	$60.00
NTNX Nutanix	Target Raised by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew Hedberg Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$49.55 +6.4%	$55.00 ➝ $58.00	Outperform
NTNX Nutanix	Reiterated by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Fish Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$49.55 +6.4%	$63.00 ➝ $60.00	Overweight
NTNX Nutanix	Target Set by	Northland Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$49.55 +6.4%	$47.00
NTNX Nutanix	Reiterated by	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$49.55 +6.4%		Overweight
NUVL Nuvalent	Reiterated by	Wedbush Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Nierengarten Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$108.57 +1.1%	$125.00	Outperform
OMC Omnicom Group	Initiated by	Rothschild & Co Redburn Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bianca Dallal Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$73.68 -1.6%	$89.00	Neutral
ON onsemi	Target Raised by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Vijay Rakesh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$124.78 -0.1%	$130.00 ➝ $150.00	Outperform
ORGO Organogenesis	Initiated by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ravi Misra Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$2.57 -3.2%	$3.00	Hold
ORGO Organogenesis	Target Set by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$2.57 -3.2%	$3.00
P Everpure	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Benjamin Swinburne Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$73.80 -13.9%	$84.00 ➝ $87.00	Equal Weight
P Everpure	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mike Cikos Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$73.80 -13.9%	$100.00	Buy
P Everpure	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Aaron Rakers Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$73.80 -13.9%	$90.00 ➝ $97.00	Overweight
P Everpure	Reiterated by	William Blair Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$73.80 -13.9%		Outperform
P Everpure	Target Raised by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tim Long Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$73.80 -13.9%	$81.00 ➝ $84.00	Equal Weight
P Everpure	Target Set by	Northland Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$73.80 -13.9%	$90.00
P Everpure	Reiterated by	Lake Street Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$73.80 -13.9%	$94.00	Buy
P Everpure	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$73.80 -13.9%	$70.00	Sell
P Everpure	Target Raised by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Howard Ma Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$73.80 -13.9%	$105.00 ➝ $115.00	Buy
P Everpure	Target Raised by	Wedbush Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matt Bryson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$73.80 -13.9%	$100.00 ➝ $105.00	Outperform
P Everpure	Reiterated by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$73.80 -13.9%		Overweight
PAYX Paychex	Reiterated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ashish Sabadra Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$95.62 +1.3%		Sector Perform
PDD PDD	Reiterated by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$81.93 -5.4%		Buy
PDD PDD	Target Lowered by	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Fawne Jiang Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$81.93 -5.4%	$160.00 ➝ $127.00	Buy
PDD PDD	Reiterated by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jiong Shao Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$81.93 -5.4%	$165.00 ➝ $89.00	Overweight ➝ Equal Weight
PETS Pets at Home Group	Reiterated by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 193.02 -2.1%	GBX 230 ➝ GBX 230	Buy
PETS Pets at Home Group	Reiterated by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 193.02 -2.1%	GBX 245 ➝ GBX 245	Buy
PGEN Precigen	Target Raised by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Swayampakula Ramakanth Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$4.49 +1.9%	$11.00 ➝ $14.00	Buy
PHR Phreesia	Target Set by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jailendra Singh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$9.45 +3.5%	$12.00
PHR Phreesia	Target Lowered by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Richard Close Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$9.45 +3.5%	$22.00 ➝ $16.00	Buy
PHR Phreesia	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Daniel Grosslight Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$9.45 +3.5%		Neutral
PHR Phreesia	Reiterated by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Clark Wright Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$9.45 +3.5%	$14.00	Buy
PODD Insulet	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joanne Wuensch Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$143.04 -2.0%	$175.00 ➝ $165.00	Neutral
PPH PPHE Hotel Group	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 1,966 +22.0%	GBX 2,050 ➝ GBX 2,050	Buy
PRHI Presurance	Target Set by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$0.67 -4.2%	$1.00
PUMP ProPetro	Initiated by	Odeon Capital Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$15.22 -3.7%		Buy
PWR Quanta Services	Upgraded by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brent Thielman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$731.28 -0.3%	$800.00	Market Perform ➝ Outperform
QLT Quilter	Target Raised by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 190.10 -1.2%	GBX 220 ➝ GBX 225	Outperform
RBA RB Global	Initiated by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Babcock Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$106.33 +2.3%	$124.00	Equal Weight ➝ Overweight
RJF Raymond James Financial	Target Lowered by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bill Katz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$142.11 -2.3%	$159.00 ➝ $155.00	Hold
RLJ RLJ Lodging Trust	Downgraded by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	RJ Milligan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$10.04 +0.9%	$9.00 ➝ $11.00	Strong-Buy ➝ Outperform
ROAD Roadside Real Estate	Reiterated by	Shore Capital Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 60 -2.4%		House Stock
ROKU Roku	Reiterated by	Citizens Jmp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew Condon Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$130.46 -1.1%	$170.00	Market Outperform
ROKU Roku	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jason Bazinet Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$130.46 -1.1%		Market Outperform
ROKU Roku	Target Set by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$130.46 -1.1%	$170.00
SATL Satellogic	Target Set by	Northland Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$9.93 +1.6%	$11.00
SBLK Star Bulk Carriers	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Stephanie Moore Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$27.28 -0.2%	$31.00	Buy
SFIX Stitch Fix	Initiated by	Northland Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Owen Rickert Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$3.71 +5.0%	$5.00	Outperform
SGHT Sight Sciences	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$5.00 +2.7%		Neutral
SHOP Shopify	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Timothy Chiodo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$112.77 +5.8%		Neutral
SMCAY SMC	Downgraded by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$21.19 +1.7%		Neutral
SNA Snap-On	Initiated by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Babcock Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$372.76 +0.2%	$420.00	Overweight
SNDK Sandisk	Target Raised by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Vijay Rakesh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1,638.91 +3.1%	$1,625.00 ➝ $1,825.00	Outperform
SNOW Snowflake	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sanjit Singh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$243.46 +38.9%	$245.00 ➝ $300.00	Overweight
SNOW Snowflake	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$243.46 +38.9%		Market Outperform
SNOW Snowflake	Target Raised by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Raimo Lenschow Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$243.46 +38.9%	$192.00 ➝ $272.00	Equal Weight
SNOW Snowflake	Reiterated by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$243.46 +38.9%	$275.00	Outperform
SNOW Snowflake	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ryan MacWilliams Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$243.46 +38.9%	$210.00 ➝ $300.00	Overweight
SNOW Snowflake	Target Raised by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mark Moerdler Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$243.46 +38.9%	$195.00 ➝ $250.00	Market Perform
SNOW Snowflake	Target Raised by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kingsley Crane Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$243.46 +38.9%	$240.00 ➝ $325.00	Buy
SNOW Snowflake	Target Raised by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kash Rangan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$243.46 +38.9%	$216.00 ➝ $278.00	Buy
SNOW Snowflake	Target Raised by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gregg Moskowitz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$243.46 +38.9%	$220.00 ➝ $295.00	Outperform
SNOW Snowflake	Target Raised by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew Hedberg Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$243.46 +38.9%	$220.00 ➝ $284.00	Outperform
SNOW Snowflake	Target Raised by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gray Powell Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$243.46 +38.9%	$235.00 ➝ $280.00	Buy
SNOW Snowflake	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brad Reback Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$243.46 +38.9%	$205.00 ➝ $300.00	Buy
SNOW Snowflake	Target Raised by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mike Cikos Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$243.46 +38.9%	$200.00 ➝ $300.00	Buy
SNOW Snowflake	Target Raised by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bradley Sills Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$243.46 +38.9%	$205.00 ➝ $300.00	Buy
SNOW Snowflake	Target Raised by	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Yi Fu Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$243.46 +38.9%	$200.00 ➝ $270.00	Buy
SNOW Snowflake	Target Raised by	Monness Crespi & Hardt Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$243.46 +38.9%	$282.00 ➝ $320.00	Buy
SNOW Snowflake	Target Raised by	Rosenblatt Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Blair Abernethy Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$243.46 +38.9%	$275.00 ➝ $285.00	Buy
SNOW Snowflake	Target Raised by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Derrick Wood Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$243.46 +38.9%	$255.00 ➝ $300.00	Buy
SNOW Snowflake	Target Raised by	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Eric Heath Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$243.46 +38.9%	$200.00 ➝ $285.00	Overweight
SNOW Snowflake	Target Raised by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gil Luria Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$243.46 +38.9%	$250.00 ➝ $300.00	Buy
SNOW Snowflake	Target Raised by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ittai Kidron Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$243.46 +38.9%	$250.00 ➝ $295.00	Outperform
SNOW Snowflake	Reiterated by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rob Owens Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$243.46 +38.9%	$230.00 ➝ $295.00	Overweight
SNOW Snowflake	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Karl Keirstead Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$243.46 +38.9%	$325.00	Buy
SNOW Snowflake	Target Raised by	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick Colville Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$243.46 +38.9%	$205.00 ➝ $285.00	Sector Outperform
SNOW Snowflake	Target Set by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Thomas Blakey Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$243.46 +38.9%	$282.00
SNOW Snowflake	Target Raised by	Wedbush Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Daniel Ives Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$243.46 +38.9%	$270.00 ➝ $280.00	Outperform
SNOW Snowflake	Target Set by	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Eric Heath Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$243.46 +38.9%	$295.00
SNOW Snowflake	Reiterated by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Miller Jump Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$243.46 +38.9%	$240.00 ➝ $275.00	Buy
SNOW Snowflake	Reiterated by	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick Colville Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$243.46 +38.9%		Outperform
SNOW Snowflake	Target Set by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$243.46 +38.9%	$300.00
SNPS Synopsys	Target Raised by	BNP Paribas Exane Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew DeGasperi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$478.92 -8.9%	$425.00 ➝ $450.00	Underperform
SNPS Synopsys	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Clarke Jeffries Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$478.92 -8.9%	$430.00 ➝ $450.00	Neutral
SNPS Synopsys	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Charles Shi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$478.92 -8.9%	$580.00	Buy
SNPS Synopsys	Target Raised by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Vivek Arya Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$478.92 -8.9%	$515.00 ➝ $600.00	Buy
SNPS Synopsys	Target Set by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$478.92 -8.9%	$558.00
SNPS Synopsys	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lee Simpson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$478.92 -8.9%	$480.00 ➝ $525.00	Equal Weight
SNPS Synopsys	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joe Quatrochi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$478.92 -8.9%	$505.00 ➝ $535.00	Equal Weight
SNPS Synopsys	Reiterated by	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$478.92 -8.9%		Overweight
SNPS Synopsys	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ruben Roy Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$478.92 -8.9%	$550.00 ➝ $600.00	Buy
SNSE Sensei Biotherapeutics	Target Set by	Loop Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Christopher Liu Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$17.00 +2.1%	$50.00
SPRY ARS Pharmaceuticals	Target Raised by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Josh Schimmer Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$9.22 +8.5%	$12.00 ➝ $30.00	Overweight
SQM Sociedad Quimica y Minera	Target Raised by	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ben Isaacson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$84.14 +0.2%	$100.00 ➝ $105.00	Sector Outperform
SRE Sirius Real Estate	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 99.25 +0.7%	GBX 110 ➝ GBX 110	Buy
STM STMicroelectronics	Reiterated by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$69.71 +2.9%		Overweight
STRL Sterling Infrastructure	Initiated by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brent Thielman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$826.43 +5.7%	$950.00	Outperform
STRO Sutro Biopharma	Initiated by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lukas Shumway Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$30.02 +1.1%	$56.00	Overweight
STZ Constellation Brands	Target Lowered by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bryan Spillane Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$142.77 -0.7%	$154.00 ➝ $152.00	Underperform
SWK Stanley Black & Decker	Target Set by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Christopher Snyder Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$79.12 -0.4%	$84.00
THKLY THK	Upgraded by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$22.42		Neutral
TNDM Tandem Diabetes Care	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$15.91 +7.4%		Neutral
TPFG The Property Franchise Group	Reiterated by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 479 +0.3%	GBX 660 ➝ GBX 660	Buy
TTAN ServiceTitan	Reiterated by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Billy Fitzsimmons Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$66.96 +5.8%		Overweight
TTD Trade Desk	Initiated by	Rothschild & Co Redburn Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bianca Dallal Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$21.33 -4.3%	$11.00	Sell
TTMI TTM Technologies	Target Raised by	B. Riley Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mike Crawford Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$187.16 -1.8%	$182.00 ➝ $208.00	Buy
TTMI TTM Technologies	Target Raised by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Ricchiuti Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$187.16 -1.8%	$160.00 ➝ $208.00	Buy
TTMI TTM Technologies	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	William Stein Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$187.16 -1.8%	$180.00 ➝ $215.00	Buy
TTMI TTM Technologies	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ruben Roy Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$187.16 -1.8%	$175.00 ➝ $205.00	Buy
ULTP Ultimate Products	Reiterated by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 50.80 -0.4%	GBX 80 ➝ GBX 80	Buy
UMC United Microelectronics	Reiterated by	BNP Paribas Exane Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$22.96 +3.3%		Neutral ➝ Underperform
VCYT Veracyte	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mike Matson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$48.17 +8.3%	$48.00	Buy
VKTX Viking Therapeutics	Initiated by	Lake Street Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Daniel Brims Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$32.19 +1.7%	$89.00	Buy
VMC Vulcan Materials	Initiated by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brent Thielman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$276.24 +0.2%		Market Perform
VMI Valmont Industries	Target Set by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brent Thielman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$525.64 +0.6%	$600.00	Outperform
VRRM Verra Mobility	Downgraded by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Chris Zhang Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$4.08 +5.8%	$23.00 ➝ $4.00	Buy ➝ Neutral
VSVS Vesuvius	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 471.73 +0.0%	GBX 545 ➝ GBX 545	Buy
VVV Valvoline	Initiated by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Babcock Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$34.25 -1.0%	$35.00	Equal Weight
WB Weibo	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$7.86 -2.8%	$9.80	Buy
WING Wingstop	Reiterated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Peter Saleh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$157.95 +3.8%	$305.00	Buy
WPP WPP	Initiated by	Rothschild & Co Redburn Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$18.86 +1.0%		Buy
WRTBY Wartsila	Downgraded by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$8.23 -3.7%		Buy ➝ Neutral
ZS Zscaler	Target Set by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$132.38 +4.7%	$200.00
ZS Zscaler	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Richard Poland Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$132.38 +4.7%	$210.00 ➝ $180.00	Overweight
ZTF Zotefoams	Reiterated by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 412 -2.1%	GBX 590 ➝ GBX 590	Buy

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 02:46 PM ET.

Stock Ratings and Recommendations: Understanding Analyst Ratings

Written by MarketBeat Staff

Key Points

Stock analysts give ratings to companies based on their research and insights.
Analysis comes from the buy side (fund companies, investment managers) or sell side (brokers, banks).
Analysts use different methodologies, so investors should always look into why a particular rating was given.
5 stocks we like better than EXA)

You'll often hear a particular stock called a "buy" or "sell," but who exactly makes these calls? Ratings and recommendations come from stock analysts, who research different securities and work for various institutions, brokerage firms and other financial companies.

Analyst ratings are designed to give additional information to investors beyond just what the company is saying, but are analyst ratings reliable? In this article, we'll discuss how to read analyst ratings, what goes into their decision-making process and how potential conflicts of interest influence analyst stock ratings.

What Are Analyst Ratings?

A stock rating is a simple heuristic given by analysts who review the firm's financial statements, listen to conference calls, chat with company executives and compare the stock to others in the industry or sector. Finally, an analyst uses all this information to produce a simple recommendation and price target.

When a public analyst goes on CNBC or the "Wall Street Journal" to give a "buy" or "sell" rating on a particular stock, they take all their research and pare it down into a simple designation. While there's no true consensus on what constitutes a buy or sell rating, an analyst usually does have "skin in the game" when devising ratings.

Ratings often pair with price targets, which put a hard number on what the analysts believe the company stock should be worth. So, for example, you might see an analyst report something like, "Buy NVIDIA Inc. (NASDAQ: NVDA), price target $350," which means that particular analyst believes investors should buy NVDA shares up to a price of $350 per share.

Analyst ratings infographic: What you need to know

What Does a Stock Analyst Do?

A stock analyst is a market professional with the skills to interpret financial data and the connections within companies to speak on the record with higher-ups. Analysts generally fall into one of two different camps: buy-side or sell-side. These positions will seem similar, but they tend to be employed by various institutions and have different responsibilities in their particular market "territories."

Buy-side analysts: Analysts on the buy side tend to work for funds, such as ETF providers or hedge funds. They don't dig as deeply into company financial data or conference calls as sell-siders. Instead, they focus on general areas or industries where their funds have vested interests. In addition, buy-side analysts often forge relationships with sell-side analysts for individual stock research. A buy-side analyst's primary goal is to find and utilize the most accurate and dependable sell-side analysts.
Sell-side analysts: If buy-side analysts work for funds (i.e., institutions that buy securities), you can probably guess which type of institution employs sell-side analysts. Brokers, banks and other firms that sell securities to investors use sell-side analysts to give reports to the public. While buy-side analysts also give ratings and price targets, the reported "buy" and "sell" ratings in financial media typically come from folks on the sell side.

Buy and sell-side analysts often use different rating systems when making their recommendations. You might even find two sell-side analysts with similar "buy" recommendations with vastly different price targets in the same stock. As a result, you'll need to familiarize yourself with the various methodologies analysts use to utilize their research correctly.

What Ratings Do Analysts Give?

Stock analyst ratings don't follow a strict structure, although most have roughly the same grading system for the securities they review. The labels may differ slightly (i.e., overweight vs. outperform), but the five most common analyst ratings go like this.

Buy

Analysts bullish on a particular security will give it a "buy" rating and set a price target above the current market price. In addition, if the analyst considers the stock one of the best in the industry or sector, you'll sometimes see a "strong buy" rating attached.

Hold

A "hold" rating is typically the lowest rating a sell-side analyst gives a stock. "Hold" means the analyst projects the stock to meet the return of the market averages, making it an unspectacular investment. Stocks rated "hold" may still have a price target above the current price, but it's not likely to surpass the return of a major index like the S&P 500.

Sell

Analysts are usually apprehensive about giving a stock a "sell" rating. For example, suppose a "hold" rating indicates indecision over the stock's future. In this scenario, a "sell" rating is issued when an analyst finds something unappealing, such as questionable accounting tactics or cratering sales growth.

Underperform

Analysts won't always give a firm "buy" or "sell" rating on stock but will instead label it "underperform" or "outperform." "Underperform" means the analyst expects the stock not to keep up with the market. It doesn't necessarily mean the analyst predicts a crash but indicates a lack of confidence in the shares.

Outperform

"Outperform" is the opposite of "underperform," meaning the analyst expects the stock to do better than the market average. It's usually considered a less confident rating than "buy."

Example of an Analyst Rating

You can use MarketBeat Analyst Ratings to find ranges and aggregates from buy- and sell-side analysts across the financial media. For example, here's a stock that analysts usually love: Alphabet Inc. (NASDAQ: GOOG).

Overview of stock analysis on GOOG Using MarketBeat's tools, you can find ratings from prominent analysts from multiple periods. Alphabet is currently labeled a "moderate buy" based on MarketBeat's consensus from 17 analysts. You'll get the consensus price target and the highest and lowest from the analysts surveyed.

Marketbeat's tools detailing analyst ratings

Looking at analyst recommendations over time is another helpful tool. For example, you can view the different levels of coverage over the last few years, which analysts changed their ratings and how the price targets vary from month to month. If an analyst can't get a good read on a particular stock they've been covering, they might choose to withhold their grade, which is one reason why the number of available ratings can change over time.

Overview of analyst ratings on MarketBeat Analysts from both sides of the aisle can be found on MarketBeat, ranging from large firms like JPMorgan Chase and Co. (NYSE: JPM) to smaller investment banks like Roth Capital. Some institutions like UBS Group offer both buy-side and sell-side ratings and analysis. These graphs show that even analysts with similar ratings can have vastly different price targets, so always understand the reasoning behind an analyst's view.

How to Use Analyst Ratings

Here are a few pointers on incorporating analyst ratings into your investment research.

Step 1: Don't rely on a single analyst.

Using an array of analysts (buy- and sell-side) gives inventors the most possible information. Don't just look for analysts with similar opinions as yourself — ensure you understand the pros and cons of each investment you make by incorporating positive and negative views, if possible.

Step 2: Compare analyst ratings across the industry or sector.

It's easy to slap a "buy" rating on a stock and predict a winner, but comparing stocks against others in the sector can offer insight into the rating. For example, if a stock is rated "buy" in the information technology sector, but a dozen others are rated "strong buy" by the same analyst, where is your capital best served?

Step 3: Consider your own goals and risk tolerance.

You might find stocks rated "strong buy" in your research in sectors you wish to avoid. That's fine! There are thousands of securities across dozens of industries in the public markets, and you don't need to purchase every share that comes with a "buy" rating. Instead, stick to your investment plan.

Step 4: Don't stubbornly stick to your original assessments.

Following your investment plan and using analyst ratings as guidelines are practical steps, but things can change over time. Today's "strong buy" stocks could be "strong sell" stocks down the road. Using an aggregate of analysts' ratings can help investors view stocks from a higher level. For example, if the number of "buy" ratings on a stock drops 40% over a few years, you might want to take a closer look at that particular company.

Why Are Analyst Ratings Important?

Checking out analyst ratings isn't a necessary step for investing, but it can be helpful for those looking to dig deep into an asset's prospects. Analyst research often has quotes from company executives, questions from conference calls and in-depth reporting on the company's balance sheet, income statement and other essential documents. Analysis like this is complex for individual investors to do on their own, especially considering how frequently analysts interact with the executives they cover. But access often comes with a downside, which we discuss more below.

How Accurate Are Analyst Ratings?

Both buy and sell-side analysts strive for accuracy because giving consistently wrong commendations can be hazardous for job security. However, investors should be aware that analysts might not always have the best interest of the retail investor at heart when making their recommendations.

For starters, being an analyst requires access to company employees and management. Analysts typically ask questions during conference calls and speak with C-suite executives on the record about their firms' prospects. Executives usually don't want to hear adverse reports about their companies, so analysts are incentivized to paint a rosy picture to retain access. The SEC has been questioning the authenticity of analyst ratings (especially on the sell-side) since 2002 when it asked bluntly, "Why are there so few sell ratings?"

Of course, there are other areas of the securities analysis market to face scrutiny. If you recall, during the 2008 financial crisis, the biggest credit rating agencies were all held to the fire due to claims that conflicts of interest influenced their ratings. The biggest rating agencies in the world were accused of "misrepresenting the risks associated with mortgage-backed securities." Remember, analyst ratings aren't spat out by computer algorithms but by living, breathing people who may have agendas other than providing the most precise and accurate reports on a company's future prospects.

Analyst Ratings Can Guide Investors, but Don't Treat Them as Gospel

Consider each type of investment research or advice in collaboration. Even the most accurate and thoughtful analysts get things wrong, plus ratings are frequently besieged with conflicts of interest. But analyst coverage does offer research that's difficult to get elsewhere, and using an array of analyst reports can give investors a deeper understanding of the securities they buy.

FAQs

Still have questions about analyst ratings? Here are a few answers to some common points of discussion:

What are analyst ratings?

Analyst ratings are the "buy" and "sell" labels, plus price targets, that investment researchers attach to specific securities. These ratings are based on financial data, earnings reports and conversations with company executives.

Should you trust analyst ratings?

Analyst ratings provide plenty of helpful information, but you shouldn't use an analyst's "buy" rating as the sole reason you purchase a security. Analysts aren't immune to conflicts of interest or outside parties' influence, so ensure you always understand why a stock was labeled a "buy" or "sell."

What does an analyst rating tell you about a stock?

Ratings give investors the analyst's overall opinion about a particular stock and price targets based on the company's valuation and prospects. Analysts often attend conference calls, ask questions and provide in-depth information about companies that are difficult to acquire elsewhere.

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Top Stock Recommendations by Brokerage

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Stock Price Targets and Analyst Ratings